Orders from 3030 CZK Free delivery from 6315 CZK Ready for pickup dead drop: collect in 5 min Free parcel delivery from 6315 CZK

Substances · Arylcyclohexylamines

3-MeO-PCE

C15H23NO CAS 1364933-83-4 Analytical reference material — not for human consumption
Preferred name
3-MeO-PCE
IUPAC name
N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine
Parent CAS number (reference)
1364933-83-4
Molecular formula
C15H23NO
Molecular weight
233.35 g/mol
InChIKey
OFGOOZLOGUNDFS-UHFFFAOYSA-N
PubChem
CID 57461569
Source
PubChem
Verified synonyms & catalog abbreviations
3-Methoxyeticyclidine Methoxieticyclidine 3MeOPCE 3-MeO PCE

Matching Listings in This Store's Catalog

Verified Neurochemical & Toxicological Intelligence

3-MeO-PCE

Serotonergic High-Potency NMDA Antagonist Arylcyclohexylamine
Verified PubChem & CAS Identity C15H23NO · CAS 1364933-83-4 / 1797121-52-8 · CID 57461569
Calibrated Physical Form Pure Crystalline / Analytical Powder (≥98%)
≥98% Analytical Purity Verified 233.35 g/mol
Peer-Reviewed & Agency Citations 2 · verified sources

Receptor Telemetry & Mechanism of Action

NMDA Uncompetitive Channel Blockade Primary
SERT / DAT Monoamine Reuptake Tone Moderate

Combines potent NMDA blockade (Ki = 61 nM) with strong SERT binding (Ki = 115 nM), yielding warm, introspective dissociation.

Biotransformation & Active Metabolites

O-demethylation and N-deethylation.

Temporal Pharmacokinetics

Serotonergic High-Potency NMDA Antagonist — Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

  1. Onset 40–90 min
  2. Peak Window 2–4 h
  3. Total Window 5–8 h
  4. Residual / Half-Life 6–16 h residual

Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

Quantitative Response Spectrum (Published Literature)

Third-person observational & toxicological brackets reported in scientific and harm-reduction literature — reference telemetry only, never consumption advice.

Threshold
3–5 mg
Cognitive & Sensory

Subtle threshold receptor activity (Serotonergic High-Potency NMDA Antagonist).

Somatic & Autonomic

Minimal baseline autonomic shift.

Light
5–10 mg
Cognitive & Sensory

Mild, clear-headed expression of primary class profile.

Somatic & Autonomic

Light somatic modulation.

Common Reference
10–16 mg
Cognitive & Sensory

Full characteristic neurochemical and perceptual profile documented in literature.

Somatic & Autonomic

Moderate somatic relaxation, ataxia, or autonomic tone depending on class.

Strong
16–22 mg
Cognitive & Sensory

Pronounced intensity, cognitive/motor impairment, or deep immersion.

Somatic & Autonomic

Marked somatic load and heightened adverse-event sensitivity.

Heavy / Toxic Zone
25+ mg
Cognitive & Sensory

Amnesia, blackout, acute dysphoria, confusion, or anesthetic dissociation.

Somatic & Autonomic

High toxicity zone: severe motor loss, cardiovascular strain, or respiratory hazard.

Interaction Matrix & Critical Contraindications

Critical Hazard — Never Combine

Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL

Severe ataxia, unconsciousness, respiratory depression, and fatal vomiting aspiration.

MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers

SERT inhibition combined with monoamine releasers or MAOIs precipitates potentially fatal serotonin syndrome and hyperthermia.

Elevated Hazard — Avoid

Strong Stimulants (Cathinones, Cocaine, Amphetamines)

Compounds hypertension, tachycardia, manic disorientation, and psychotic episodes.

Caution / Receptor Attenuation

Cannabis & Psychedelics

Dramatically intensifies dissociation, confusion, and sensory immersion.

Structural Isomer & Sibling Comparison

Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs.

Physicochemical Stability & Storage

Physical Form: White to off-white crystalline powder or fine crystals. · Soluble in water, ethanol, and saline.

Chemically stable when kept dry, sealed, and protected from light at room temperature.

Cross-Tolerance & Dependence Profile

Slowly decaying NMDA cross-tolerance shared across all arylcyclohexylamines (halves in ~3–7 days, full baseline 2+ weeks). Chronic frequent exposure carries documented urological/bladder epithelial toxicity.

Spot-test and isomer verification

Spot-test notes for 3-MeO-PCE. Morris shifts grey-blue to slate-blue, not the lilac-purple of ketamine HCl.

Spot tests and routine EI-MS cannot separate ring regioisomers, especially 3-FXE (CID 137332183) from the ortho isomer 2F-NENDCK (CAS 2850352-64-4); differentiation requires ATR-FTIR (700–900 cm⁻¹ ring-substitution bands) or ¹⁹F-NMR and ¹H-NMR.

Codes on this card

Short meanings for the abbreviations printed with this substance.

Open the full glossary →
DAT Dopamine transporter

DAT is the protein that collects dopamine back from the gap between nerve cells. A card that names DAT is quoting a laboratory result about that protein.

SERT Serotonin transporter

SERT is the protein that collects serotonin back into the nerve cell. A higher number than at DAT means the serotonin transporter needed more concentration to reach the halfway point.

NMDA NMDA glutamate channel

NMDA is a glutamate receptor that works like a gated channel. Ketamine-type and PCP-type cards cite it when papers describe that channel as blocked.

EC₅₀ / IC₅₀ Halfway concentration

EC50 is the concentration where a lab saw half of the maximum measured effect. IC50 is the concentration where it saw half of the maximum block. Smaller means that halfway point came at a lower concentration.

Kᵢ Binding tightness in nanomoles

Ki says how tightly a compound sits on a receptor in a binding test. It is written in nanomoles per litre. A Ki of 1 nM means very tight binding in that experiment.

ratio Selectivity ratio

A selectivity ratio divides two halfway numbers, such as SERT EC50 by DAT EC50, to show which target the assay reached first. The direction of the division has to be stated, or the number flips.

T½ Half-life

Half-life is the time it takes a measured concentration to fall by half. After one half-life, half remains. After another, a quarter of the original measurement remains.

Tolerancja × Cross-Tolerance

When exposure to one compound reduces sensitivity to other compounds that act on the same receptor family (for example across all 5-HT2A lysergamides or all GABA-A modulators).

Comprehensive Analytical & Toxicological Monograph

3-MeO-PCE (N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine; CAS 1364933-83-4, PubChem CID 57461569) is a arylcyclohexylamine reference compound (C15H23NO, 233.35 g/mol) classified pharmacologically as a Serotonergic High-Potency NMDA Antagonist. Combines potent NMDA blockade (Ki = 61 nM) with strong SERT binding (Ki = 115 nM), yielding warm, introspective dissociation. O-demethylation and N-deethylation. In published observational and toxicological literature, threshold response is noted at 3–5 mg, light range at 5–10 mg, common reference range at 10–16 mg, strong intensity at 16–22 mg, and heavy/adverse territory at 25+ mg, with an onset of 40–90 min, peak window of 2–4 h, and total duration of 5–8 h (6–16 h residual). Warmer and more serotonergic-leaning than 3-MeO-PCP or O-PCE (common 10–16 mg), with strict contraindication against serotonergic drugs. Critical contraindications include Alcohol, Opioids (O-DSMT), Benzodiazepines, and GHB/GBL, MAOIs, MDMA, 4-MMC, 3-CMC, and Serotonin Releasers.

Chemical Architecture & Structural Profile

3-MeO-PCE (N-ethyl-1-(3-methoxyphenyl)cyclohexan-1-amine) is a reference compound belonging to the Arylcyclohexylamines class, characterized by the molecular formula C15H23NO and a molar mass of 233.35 g/mol. The parent molecule is indexed under CAS registry number 1364933-83-4 and in the NCBI PubChem database as CID 57461569 (Standard InChIKey: OFGOOZLOGUNDFS-UHFFFAOYSA-N). This molecule shares its empirical formula (C15H23NO) with positional or structural isomers; unambiguous analytical identification requires matching the full IUPAC structure, CAS number (1364933-83-4), and spectroscopic profile.

Citations

Reference Toxicology & Safety Profile

In documented chemical and harm-reduction literature (PubChem / PsychonautWiki, CC BY 4.0), 3-MeO-PCE is indexed within the Arylcyclohexylamines structural group. Toxicological notes (PsychonautWiki): toxic threshold is unknown. Dependence liability (PsychonautWiki): highly addictive with a high potential for adverse side effects such as psychosis. Documented cross-tolerance class: dissociatives. Standard laboratory handling precautions—including nitrile gloves, eye protection, and local exhaust ventilation—apply whenever handling the reference material.

Citations

Analytical Use & Laboratory Notice

This reference sheet provides chemical, analytical, and toxicological provenance only. The material is strictly not for human consumption, diagnostic, or veterinary use. Research-use labelling does not establish legal status in any jurisdiction.

Citations

Documented Contraindications & Interactions

High-risk / Dangerous combinations